Fairmont Banff Springs Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

This meeting took place in 2003



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

2003 Fellows and New Investigators Workshop on HIV-(Concurrent with 2003 Keystone Symposia, Twenty Years of HIV Research and HIV Vaccine Development) (P1)


Organizer(s) Opendra K. Sharma and Patricia A. Baron
March 28—April 4, 2003
Fairmont Banff Springs • Banff, Alberta Canada
Abstract Deadline: Dec 31, 2002
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Jan 29, 2003

National Institute of Allergy and Infectious Diseases/National Institutes of Health

Summary of Meeting:
The workshop will provide opportunities for postdoctoral fellows/trainees and new investigators to network with leading HIV/AIDS researchers and to promote collaborations between investigators using innovative and novel approaches to basic biological research, clinical/epidemiological research, and research on HIV vaccines and microbicides.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


FRIDAY, MARCH 28


SATURDAY, MARCH 29

07:30—08:30
Registration

Van Horne Foyer
07:30—08:30
Breakfast

Van Horne C
08:30—10:15
Plenary Session I
Meeting has ended...abstracts no longer viewable online.

Theatre CC
* Carl W. Dieffenbach, NIAID, National Institutes of Health, USA

José G. Esparza, Bill & Melinda Gates Foundation, USA
Fifteen Years of HIV Vaccine Clinical Trials: Lessons Learned and Current Challenges

Ashley T. Haase, University of Minnesota, USA
30 Years of Lentivirus Pathogenesis Research: Lessons Learned and Current Challenges

10:15—10:30
Coffee Break

Theatre Foyer
10:30—12:30
Plenary Session II
Meeting has ended...abstracts no longer viewable online.

Theatre-CC
* Julie M. Overbaugh, Fred Hutchinson Cancer Research Center, USA

Alexandre Harari, Centre Hospitalier Universitaire Vaudois, Switzerland
Short Talk: Relationship between Functional and Qualitative Abnormalities within the Pool of HIV-1-Specific Memory CD4 T Cells and Control of HIV-1 Disease

Catarina E. Hioe, Icahn School of Medicine at Mount Sinai, USA
Short Talk: Antibodies to the CD4 Binding Domain of gp120 Interfere with gp120 Proteolysis and Antigen Presentation to CD4 T Cells

Barbara L. Shacklett, University of California, Davis, USA
Short Talk: Antigen-Specific CD8+ T-Cells in Gut-Associated Lymphoid Tissue (GALT) during Chronic infection

Ramothea L. Webster, Harvard Medical School, USA
Short Talk: Phenotypic and Functional Analysis of Rhesus macaque Natural Killer Cells

Marie J. Estcourt, University of Western Australia,
Short Talk: Prime-Boost Immunization Generates High Avidity CD8 T Cell Populations

12:30—14:00
Poster Setup

Shaughnessy/Coleman/Beatty
14:00—15:30
Grantsmanship and Career Development
Meeting has ended...abstracts no longer viewable online.

Theatre-CC
* Susan F. Plaeger, NIAID, National Institutes of Health, HHS, USA

Julie M. Overbaugh, Fred Hutchinson Cancer Research Center, USA

Opendra K. Sharma, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA

Jonathan T. Warren, NIAID, National Institutes of Health, USA

Dianne E. Tingley, NIAID, National Institutes of Health, USA

16:00—17:00
Social Hour

Shaughnessy/Coleman/Beatty

SUNDAY, MARCH 30

Virus Diversity and Replication (Tutorial)
* Robert W. Doms, University of Pennsylvania School of Medicine, USA

Richard B. Gaynor, Neon Therapeutics, USA

James E.K. Hildreth, UC Davis College of Biological Sciences, USA

Phyllis J. Kanki, Harvard School of Public Health, USA

Bette Tina Marie Korber, Los Alamos National Laboratory, USA

Dan R. Littman, HHMI/New York University School of Medicine, USA

David I. Watkins, University of Miami, USA

19:30—20:30
Social Hour

Alhambra

MONDAY, MARCH 31

19:30—20:30
Vaccine Approaches (Tutorial)

Alhambra
* Harriet L. Robinson, GeoVax Inc., USA

Phillip W. Berman, University of California, Santa Cruz, USA

Deborah L. Birx, Centers for Disease Control and Prevention, USA

Emilio A. Emini, Bill and Melinda Gates Foundation, USA

Barney S. Graham, NIAID, National Institutes of Health, USA

M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA

Andrew J. McMichael, Oxford University, UK

19:30—20:30
Social Hour

Alhambra

TUESDAY, APRIL 1

Immune Responses and HIV Pathogenesis (Tutorial)
* Richard A. Koup, NIAID, National Institutes of Health, USA

Bruce A. Beutler, University of Texas Southwestern Medical Center, USA

Mary Carrington, Frederick National Laboratory for Cancer Research, USA

Daniel C. Douek, NIAID, National Institutes of Health, USA

Alan L. Landay, Rush Medical University, USA

Jay A. Levy, University of California, San Francisco, USA

David C. Montefiori, Duke University Medical Center, USA

Douglas F. Nixon, George Washington University, USA

19:30—20:30
Social Hour

Alhambra

WEDNESDAY, APRIL 2

19:30—20:30
Targeting Viral Reservoirs and Immune Protection (Tutorial)

Alhambra
* Bruce D. Walker, Ragon Institute of MGH, MIT and Harvard, USA

Brigitte Autran, Hôpital Pitié-Salpétrière, UPMC, France

Michael M. Lederman, Case Western Reserve University, USA

Douglas D. Richman, University of California, San Diego, USA

Robert F. Siliciano, Johns Hopkins University School of Medicine, USA

19:30—20:30
Social Hour

Alhambra

*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676